A- A A+

Crack cocaine users views regarding treatment with contingency management in Brazil

André Q. C. Miguel, Clarice S. Madruga, Viviane Simões, Rodolfo Yamauchi, Claudio J. da Silva, Renata R. Abdalla, Michael McDonell, Sterling McPherson, John M. Roll, Jair J. Mari and Ronaldo R. Laranjeira

Substance Abuse Treatment, Prevention, and Policy2018, 13:7, doi.org/10.1186/s13011-018-0144-7


A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.

Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD.

Addict Res Theory. 2016;24(6):490-498. doi: 10.3109/16066359.2016.1173682.


Neural mechanisms of extinguishing drug and pleasant cue associations in human addiction: role of the VMPFC.

Konova, A. B., Parvaz, M. A., Bernstein, V., Zilverstand, A., Moeller, S. J., Delgado, M. R., Alia-Klein, N., and Goldstein, R. Z. (2017)

Addiction Biology, doi: 10.1111/adb.12545.



Oxytocin protocol appears workable and safe for methadone patients who use cocaine

Some 30 to 60 percent of patients in methadone maintenance therapy (MMT) for opioid use disorders use cocaine. Compared to other MMT patients, those who use cocaine have higher rates of relapse and mortality. Studies with animals have suggested that the hormone oxytocin could be doubly helpful to these patients, by reducing the addictive effects of both opioids and cocaine. Now, researchers supported by the National Institute on Drug Abuse have developed a protocol for adjunctive oxytocin treatment, and a pilot study has indicated that it is workable and safe for MMT patients. (NIDA, Science Highlight, 09.01.2018)


Cocaine-addicted individuals say they find the drug much less enjoyable after years of use, but they have great difficulty quitting. A new brain imaging study led by researchers at the Icahn School of Medicine at Mount Sinai reveals why this might be so, as well as why a common psychological therapy may not work in addicted cocaine users. (The Mount Sinai Hospital / Mount Sinai School of Medicine, 11.09.2017)


Why Females Are More Sensitive to Cocaine

This research:

Examined why females are more sensitive than males to the rewarding and motivational effects of stimulant drugs.

Demonstrated that the female hormone estradiol is responsible for the increased sensitivity.

Identified two signaling pathways—mGluR5 and the cannabinoid CB1R pathways—through which estradiol mediates enhanced escalation of drug administration and greater euphoria in females. (NIDA Notes, 03.08.2017)


"I love having benzos after my coke shot": The use of psychotropic medication among cocaine users in downtown Montreal.

Motta-Ochoa R, Bertrand K, Arruda N, Jutras-Aswad D, Roy É.

Int J Drug Policy. 2017 Aug 18;49:15-23. doi: 10.1016/j.drugpo.2017.07.012.



Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

Shen Q, Deng Y, Ciccocioppo R, Cannella N.

Front Psychiatry. 2017 Nov 13;8:234. doi: 10.3389/fpsyt.2017.00234.


Cocaine adulteration.

Kudlacek O, Hofmaier T, Luf A, Mayer FP, Stockner T, Nagy C, Holy M, Freissmuth M, Schmid R, Sitte HH.

J Chem Neuroanat. 2017 Jun 12. pii: S0891-0618(17)30003-0. doi: 10.1016/j.jchemneu.2017.06.001.



Neural mechanisms of extinguishing drug and pleasant cue associations in human addiction: role of the VMPFC.

Konova AB, Parvaz MA, Bernstein V, Zilverstand A, Moeller SJ, Delgado MR, Alia-Klein N, Goldstein RZ.

Addict Biol. 2017 Sep 5. doi: 10.1111/adb.12545.



Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.

Kallupi M, Shen Q, de Guglielmo G, Yasuda D, Journigan VB, Zaveri NT, Ciccocioppo R.

Addict Biol. 2017 Jun 21. doi: 10.1111/adb.12513.



NASHVILLE — For the first time, Tennessee Bureau of Investigation scientists have detected fentanyl, a potentially deadly narcotic, mixed in with samples of cocaine. (USA Today, 20.10.2017)


In 2016, 37 percent of overdose deaths involved cocaine and fentanyl without heroin, up from 11 percent in 2015

Last year more than 1,300 New Yorkers died of a drug overdose, and nearly half (44 percent) of those deaths involved fentanyl. (New York City Health Department, 01.06.2017)


Persons addicted to cocaine often find that the drug is much less enjoyable after years of use, yet they have great difficulty quitting. A new brain imaging study shows why this may be so and also why extinction-based therapy may not be effective for cocaine users.

The study, led by researchers at the Icahn School of Medicine at Mount Sinai in New York City, found that in long-term cocaine users, there is global impairment in the ventromedial prefrontal cortex (VMPFC), an area of the brain that is linked to impulse and self-control. (Medscape, 15.09.2017)


Education and equipment for people who smoke crack cocaine in Canada: progress and limits

Carol Strike and Tara Marie Watson

Harm Reduction Journal 2017 14:17, DOI: 10.1186/s12954-017-0144-3


Cocaine Cue-Induced Dopamine Release in Recreational Cocaine Users.

Cox SML, Yau Y, Larcher K, Durand F, Kolivakis T, Delaney JS, Dagher A, Benkelfat C, Leyton M.

Sci Rep. 2017 Apr 26;7:46665. doi: 10.1038/srep46665.


Risk behaviors for sexually transmitted diseases among crack users.

Guimarães RA, da Silva LN, França DD, Del-Rios NH, Carneiro MA, Teles SA.

Rev Lat Am Enfermagem. 2015 Jul-Aug;23(4):628-34. doi: 10.1590/0104-1169.0077.2597.


Assessment of inhibitory control in crack and/or cocaine users: a systematic review.

Czermainski FR, Willhelm AR, Santos ÁZ, Pachado MP, de Almeida RMM.

Trends Psychiatry Psychother. 2017 Aug 14:0. doi: 10.1590/2237-6089-2016-0043.


Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine - A Systematic Review and Meta-analysis.

Ashok AH, Mizuno Y, Volkow ND, Howes OD. JAMA Psychiatry. 2017;74(5):511-519. doi:10.1001/jamapsychiatry.2017.0135



Authorities in the northern Spanish city of Bilbao are distributing cards for people to crush cocaine with prior to snorting, in a bid to reduce the potential harms of nasal drug use – including the spread of hepatitis C. (Talking Drugs, UK, 12.09.2017)